Page last updated: 2024-08-26

u 74006f and Body Weight

u 74006f has been researched along with Body Weight in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunn, C; Sun, FF; Wong, PY; Yin, K; Yue, G	1
Andiné, P; Bågenholm, R; Hagberg, H	1
Fleishaker, JC; Hopkins, NK; Pearson, LK; Pearson, PG; Peters, GR; Wienkers, LC	1
Fiedler-Kelly, J; Fleishaker, JC; Grasela, TH	1
Bennet, W; Czech, KA; Larsson, LC; Mirza, B; Song, Z; Wennberg, L; Widner, H	1

Trials

1 trial(s) available for u 74006f and Body Weight

Article	Year
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A. Journal of clinical pharmacology, 1999, Volume: 39, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antioxidants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Metabolic Clearance Rate; Midazolam; Middle Aged; Oxidoreductases, N-Demethylating; Postmenopause; Pregnatrienes; Premenopause; Progesterone	1999

Article

Year

Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.

Journal of clinical pharmacology, 1999, Volume: 39, Issue:3

Topics: Adolescent; Adult; Age Factors; Aged; Antioxidants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Metabolic Clearance Rate; Midazolam; Middle Aged; Oxidoreductases, N-Demethylating; Postmenopause; Pregnatrienes; Premenopause; Progesterone

1999

Other Studies

4 other study(ies) available for u 74006f and Body Weight

Article	Year
The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:1 Topics: Animals; Antioxidants; Body Weight; Colitis; Colon; Free Radical Scavengers; Inflammatory Bowel Diseases; Lipid Peroxides; Luminescent Measurements; Male; Organ Size; Peroxidase; Pregnatrienes; Rats; Rats, Sprague-Dawley; Superoxides; Trinitrobenzenesulfonic Acid	1996
Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat. Pediatric research, 1996, Volume: 40, Issue:3 Topics: Animals; Antioxidants; Body Weight; Brain Damage, Chronic; Brain Edema; Brain Ischemia; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Hypoxia, Brain; Neuroprotective Agents; Pregnatrienes; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Statistics as Topic	1996
Population pharmacokinetics of tirilazad: effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage. Pharmaceutical research, 1999, Volume: 16, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antioxidants; Body Weight; Drug Interactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Multivariate Analysis; Phenytoin; Pregnatrienes; Sex Factors; Subarachnoid Hemorrhage	1999
Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats. Transplantation, 2001, Jun-27, Volume: 71, Issue:12 Topics: Animals; Antibody Formation; Body Weight; Brain; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Drug Therapy, Combination; Fetal Tissue Transplantation; Graft Survival; Immunosuppressive Agents; Lipid Peroxidation; Macrophages; Male; Mice; Mice, Nude; Nerve Tissue; Neurons; Neuroprotective Agents; Pregnatrienes; Preservation, Biological; Rats; Rats, Inbred Lew; Survival Analysis; Swine; Transplantation, Heterologous	2001